Wei J. Duan

20 Nanxincun, Xiangshan Road
Xiangshan, 100093, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Neurotropism and interferon-dominated immune responses in a mouse-adapted coxsackievirus A16 infection model.

Neurotropism and interferon-dominated immune responses in a mouse-adapted coxsackievirus A16 infection model.

Journal: Journal of virology

Published: June 30, 2026

Niraparib treatment patterns and outcomes in first-line maintenance therapy for ovarian cancer: The RENI-1 study.

Niraparib treatment patterns and outcomes in first-line maintenance therapy for ovarian cancer: The RENI-1 study.

Journal: Chinese medical journal

Published: December 23, 2025

SHFL Post-Transcriptionally Restricts Coxsackievirus A16 In Vitro and In Vivo.

SHFL Post-Transcriptionally Restricts Coxsackievirus A16 In Vitro and In Vivo.

Journal: Viruses

Published: December 17, 2025

Salmonella Bacteria Membrane-Fusion Paclitaxel Loaded Liposomes for Enhanced Therapy of Intraperitoneal Metastatic Ovarian Cancer.

Salmonella Bacteria Membrane-Fusion Paclitaxel Loaded Liposomes for Enhanced Therapy of Intraperitoneal Metastatic Ovarian Cancer.

Journal: Advanced healthcare materials

Published: November 27, 2025

Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model.

Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model.

Journal: Viruses

Published: September 21, 2025

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Journal: CA: a cancer journal for clinicians

Published: September 15, 2025

Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension

Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: August 10, 2025

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors.

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors.

Journal: Experimental hematology & oncology

Published: July 24, 2025

Pathological characteristics of a murine oral coxsackievirus A10 infection model.

Pathological characteristics of a murine oral coxsackievirus A10 infection model.

Journal: Journal of virology

Published: July 01, 2025

EGAvatar: Efficient GAN Inversion for Generalizable Head Avatar From Few-Shot Images.

EGAvatar: Efficient GAN Inversion for Generalizable Head Avatar From Few-Shot Images.

Journal: IEEE transactions on visualization and computer graphics

Published: June 02, 2025

Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.

Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.

Journal: Cell reports. Medicine

Published: May 29, 2025

ARFGAP1 serves as a critical host factor during E30 infection: QS11 inhibits viral pathogenesis in hFcRn-IFNAR-/- mice.

ARFGAP1 serves as a critical host factor during E30 infection: QS11 inhibits viral pathogenesis in hFcRn-IFNAR-/- mice.

Journal: Virology journal

Published: May 12, 2025

Showing 1-12 of 101

Last Updated: 09/26/2026